Trandolapril in overweight patients with mild-to-moderate essential hypertension: the turkish multicenter trandolapril study

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Current Therapeutic Research-clinical and Experimental

• Publication date

  1996-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0011-393X(96)80116-0
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Hypertension and associated metabolic abnormalities--the role of insulin resistance and the sympathoadrenal system.

  1996cited by this paper
• Insulin Sensitivity in Obese Hypertensive Dyslipidemic Patients Treated with Enalapril or Atenolol

  1995cited by this paper
• Long-term therapy with trandolapril, a new nonsulfhydryl ACE inhibitor, in hypertension: a multicenter international trial. Investigator Study Group.

  1994cited by this paper
• Comparison of the Efficacy and Safety of Trandolapril and Nifedipine SR in Mild‐to-Moderate Hypertension

  1994cited by this paper
• Double‐Blind Comparison of the Efficacy and Safety of Trandolapril 2 mg and Hydrochlorothiazide 25 mg in Patients with Mild‐to-Moderate Essential Hypertension

  1994cited by this paper
• Long‐Term Therapy with Trandolapril, a New Nonsulfhydryl ACE Inhibitor, in Hypertension: A Multicenter International Trial

  1994cited by this paper
• Comparison of the Efficacy and Safety of Trandolapril and Captopril for 16 Weeks in Mild‐to-Moderate Essential Hypertension

  1994cited by this paper
• Trandolapril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in essential hypertension.

  1994cited by this paper
• Trandolapril. How does it differ from other angiotensin converting enzyme inhibitors?

  1993cited by this paper
• Once‐Daily Trandolapril Compared with the Twice‐Daily Formulation in the Treatment of Mild to Moderate Essential Hypertension: Assessment by Conventional and Ambulatory Blood Pressures

  1993cited by this paper
• Clinical experiences with trandolapril.

  1993cited by this paper
• The pathogenesis of hypertension in obese subjects. Discussion

  1993cited by this paper
• Effects of chronic angiotensin converting enzyme inhibition on glucose tolerance and insulin sensitivity in essential hypertension.

  1992cited by this paper
• Trandolapril in hypertension: overview of a new angiotensin-converting enzyme inhibitor.

  1992cited by this paper
• Hypertension, obesity and response to antihypertensive treatment: results of a community survey.

  1992cited by this paper
• Prospects for cardioreparation.

  1992cited by this paper
• Relationship of fasting serum insulin concentrations with blood pressure in a representative sample of the adult population of the Seychelles.

  1991cited by this paper
• Effects of Antihypertensive Treatment on Insulin Sensitivity With Special Reference to ACE Inhibitors

  1991cited by this paper
• Obesity, Glucose Intolerance, Hyperinsulinemia, and Response to Antihypertensive Drugs

  1991cited by this paper
• Insulin resistance is a characteristic feature of primary hypertension independent of obesity.

  1990cited by this paper
• A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension.

  1989cited by this paper
• Captopril enhances insulin responsiveness of forearm muscle tissue in non‐insulin‐dependent diabetes mellitus

  1987cited by this paper
• Recommendations on blood pressure measurement.

  1986cited by this paper
• Cecil Textbook of Medicine

  1985cited by this paper
• Obesity as an Independent Risk Factor for Cardiovascular Disease: A 26‐year Follow‐up of Participants in the Framingham Heart Study

  1983cited by this paper
• The preservation of cadaveric kidneys for transplantation.

  1970cited by this paper

• Efficacy and Tolerability of Trandolapril in Mildto- moderate Hypertension: A Double-blind Comparison with Enalapril.

  2012cites this paper
• Trandolapril: a newer angiotensin-converting enzyme inhibitor.

  2003cites this paper
• Duration of Trandolapril Antihypertensive Effect after 24 and 48 Hours from Last Dose THOR Study

  1999cites this paper
• Trandolapril. An update of its pharmacology and therapeutic use in cardiovascular disorders.

  1998influential citation